Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed	Analyse	im Forum	Fonds	Senden
Historisch	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

29.05.08	Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
08.05.08	Par Pharmaceutical Reports First Quarter 2008 Results
07.05.08	Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
05.05.08	Par Pharmaceutical to Host First Quarter 2008 Earnings Conference Call on May 9 at 9:00 AM
21.04.08	ANALYSE: Needham bestätigt Yahoo! vor Zahlen mit 'Hold'
21.04.08	Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
29.02.08	Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
25.02.08	Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
15.01.08	Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
15.01.08	Alfacell Corporation Licenses ONCONASE(R) U.S. Commercial Rights to Strativa Pharmaceuticals

28.12.07	Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
20.12.07	Par Pharmaceutical Reports Third-Quarter 2007 Results
12.12.07	AstraZeneca leitet Patentverletzungsverfahren gegen sieben Generikahersteller wegen Crestor ein
21.11.07	Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007
15.10.07	Barr and Par Settle Diazepam Rectal Gel Patent Challenge with Valeant
15.10.07	Par Pharmaceutical Enters into Agreement with Valeant Pharmaceuticals to Settle Patent Litigation over Diastat(R) and Diastat(R) AcuDial(TM)
28.09.07	Introducing Strativa Pharmaceuticals
28.09.07	Par Pharmaceutical Provides Summary of Analyst/Investor Day
27.09.07	Chinese SFDA Grants Immtech Fast Track Status
24.09.07	Par Invites Public to Listen to Webcast of its September 28 Analysts' Meeting
06.09.07	Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts' Meeting September 28, 2007
09.08.07	Patrick G. Lepore Elected Chairman of Board of Directors, Joseph E. Smith Named Lead Director of Par Pharmaceutical Companies, Inc.
03.08.07	Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
02.08.07	Par Pharmaceutical Announces Equity Investment in IntelliPharmaCeutics Ltd.
01.08.07	Par Pharmaceutical Licenses North American Rights to Zensana(TM) from Hana Biosciences
30.07.07	Par Pharmaceutical Files Form 10-Q/A for Third Quarter of 2006
26.07.07	Par Pharmaceutical Begins Shipment of Additional Dosage Strengths of Generic TOPROL-XL(R)
19.07.07	Par Pharmaceutical Announces Agreement with Ortho-McNeil to Settle Ultracet(R) Patent Litigation
10.07.07	Par Pharmaceutical Files Form 10-Q/As for First and Second Quarters of 2006
03.07.07	Par Pharmaceutical Licenses U.S. Commercialization Rights to Loramyc(TM) From BioAlliance Pharma
12.06.07	Par Pharmaceutical Licenses Commercialization Rights to Pafuramidine for Treatment of Pneumocystis Pneumonia
12.06.07	Immtech and Par Enter Licensing Agreement on Pafuramidine for Treatment of Pneumocystis Pneumonia
07.06.07	Par Pharmaceutical Names Gerard A. Martino EVP and COO, Veronica A. Lubatkin EVP and CFO
23.05.07	Par Pharmaceutical to Present at 2007 Friedman Billings Ramsey Growth Conference
05.04.07	Par Pharmaceutical to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
22.03.07	Par Begins Shipment of Generic Zantac Syrup(R)
13.03.07	Par Pharmaceutical Files Form 10-K/A With SEC
13.03.07	Par Pharmaceutical To Present at Lehman Brothers' Tenth Annual Global Healthcare Conference
08.03.07	Melvin Sharoky Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
07.03.07	Par Pharmaceutical to Present at Cowen and Company 27th Annual Health Care Conference

Finanzen.net

Par Pharmaceutical Cos Aktie [WKN: A0B5R1 / ISIN: US69888P1066]

Hinweis

Newssuche

ALLE Nachrichten zur Par Pharmaceutical Cos. Inc.

Anzeige

ANZEIGE